2005
“NDAs, ANDAs, Patents, and Exclusivity” at the Food and Drug Law Institute
This event has already occurred.
Related Insights
Unraveling a Tangled Net of Claims: Jury Split on a Jellyfish-Derived Supplement Product
Unraveling a Tangled Net of Claims: Jury Split on a Jellyfish-Derived Supplement Product
April 18, 2024
3min
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed for Lack of Jurisdiction
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed for Lack of Jurisdiction
April 17, 2024
2min
Not So Fast: FTC Letter Rebukes Direct Selling Self-Regulatory Council Guidance
Not So Fast: FTC Letter Rebukes Direct Selling Self-Regulatory Council Guidance
April 17, 2024
3min
Events
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
April 25 - 26, 2024 New York, NY - American Conference Institute
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
April 25, 2024 Washington, DC - Venable
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
May 01 - 03, 2024 New Orleans, LA - Financial Counseling Association of America (FCAA)